跳至主要内容
临床试验/NL-OMON36314
NL-OMON36314已完成不适用

OSU6162 as a potential novel drug treatment for Parkinson's disease: effects on dopamine D2 receptor binding in human brain studied using PET. - Effects of OSU6162 on dopamine D2 receptor binding in human brain.

Vrije Universiteit Medisch Centrum0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Investigational group:
  • healthy volunteers (males)
  • Age between 50-60 years
  • Good physical health evaluated by medical history, physical (including neurological) examination RDC (Research Diagnostic Criteria) diagnosis never mentally ill

排除标准

  • Exclusion criteria include a history of a neurological or psychiatric disorder, the use of any centrally active medication, drug abuse (a toxicology screening of urine will be performed to detect opiates, cocaine, amphetamines, cannabis, methadone, benzodiazepines and barbiturates), and participation in other studies involving radiation exposure.

研究者

相似试验